- Home»
- The Billing Beat Newsletter»
- Excellus (#2.02.60) Germline Genetic Testing for Hereditary Cancers//New Policy
Excellus (#2.02.60) Germline Genetic Testing for Hereditary Cancers//New Policy
February 12, 2024This new medical policy was created to combine the criteria from corporate medical policies #2.02.06 Genetic Testing for Hereditary BRCA Mutations, #2.02.07 Genetic Testing for Germline Mutations of the RET Proto Oncogene in Medullary Carcinoma of the Thyroid, #2.02.11 Genetic Testing for Inherited Susceptibility to Colorectal Cancer, and #2.02.44 Genetic Testing for Susceptibility to Hereditary Cancers.
The source page for this article has moved or has expired.
Please visit the Billing Beat News or Beyond Billing Blog for relevant information or search our site for specific information related to this article.
Original source URL:
https://provider.excellusbcbs.com/documents/d/excellus-provider/february-2024-connection-newsletter